Emergence of resistance in Pseudomonas aeruginosa and Acinetobacter species after the use of antimicrobials for burned patients

被引:25
|
作者
Ferreira, ACB [1 ]
Gobara, S [1 ]
Costa, SF [1 ]
Sauaia, N [1 ]
Mamizuka, EM [1 ]
Van der Heijden, IM [1 ]
Soares, RE [1 ]
Almeida, GD [1 ]
Fontana, C [1 ]
Levin, AS [1 ]
机构
[1] Univ Sao Paulo, Fac Med, Hosp Clin, Sao Paulo, SP, Brazil
来源
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY | 2004年 / 25卷 / 10期
关键词
D O I
10.1086/502311
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
OBJECTIVES: To evaluate the emergence of resistance of Pseudomonas aeruginosa and Acinetobacter species to imipenem, ciprofloxacin, or both after the use of these drugs and to compare resistant with susceptible isolates by molecular typing. DESIGN: Cohort study. SETTING: Burn intensive care unit (ICU) with 4 beds in a tertiary-care university hospital. METHODS: During 16 months, surveillance cultures were performed for all patients admitted to the ICU. Demographic information was obtained for each patient. Molecular typing was done by pulsed-field gel electrophoresis using restriction enzymes for 71 isolates of P aeruginosa and Acinetobacter species. RESULTS: Thirty-four patients were admitted and 22 were colonized by susceptible P aeruginosa or Acinetobacter species before they used the antimicrobials. Nine (41%) of these patients had a resistant isolate after antimicrobial use: 5 had used imipenem alone, I had used ciprofloxacin, and 3 had used both drugs. The interval between isolation of the susceptible and resistant isolates ranged from 4 to 25 days, but was 10 or more days for 6 patients. Molecular typing revealed that susceptible and resistant isolates from each patient were different and that although there were no predominant clones among susceptible isolates, there was a predominant clone among resistant isolates of P aeruginosa and of Acinetobacter. CONCLUSIONS: Resistance was not due to the acquisition of resistance mechanisms by a previously susceptible strain, but rather to cross-transmission. Although various measures involving antimicrobial use have received great attention, it would seem that practices to prevent cross-transmission are more important in controlling resistance.
引用
收藏
页码:868 / 872
页数:5
相关论文
共 50 条
  • [31] EMERGENCE OF RESISTANCE TO IMIPENEM DURING THERAPY FOR PSEUDOMONAS-AERUGINOSA INFECTIONS
    QUINN, JP
    DUDEK, EJ
    DIVINCENZO, CA
    LUCKS, DA
    LERNER, SA
    JOURNAL OF INFECTIOUS DISEASES, 1986, 154 (02): : 289 - 294
  • [32] EMERGENCE OF QUINOLONE-IMIPENEM CROSS-RESISTANCE IN PSEUDOMONAS-AERUGINOSA AFTER FLUOROQUINOLONE THERAPY
    AUBERT, G
    POZZETTO, B
    DORCHE, G
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1992, 29 (03) : 307 - 312
  • [33] Emergence of Polymyxin B Resistance Influences Pathogenicity in Pseudomonas aeruginosa Mutators
    Bulman, Zackery P.
    Sutton, Mark D.
    Ly, Neang S.
    Bulitta, Jurgen B.
    Holden, Patricia N.
    Nation, Roger L.
    Li, Jian
    Tsuji, Brian T.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2015, 59 (07) : 4343 - 4346
  • [34] STUDIES OF EMERGENCE OF RESISTANCE TO IMPENEM BY PSEUDOMONAS-AERUGINOSA DURING THERAPY
    MOBLEY, HLT
    DRUSANO, GL
    SALATA, RA
    SCHELD, WM
    CLINICAL RESEARCH, 1985, 33 (03): : A765 - A765
  • [35] Psl-Dependent Cooperation Contributes to Drug Resistance of Pseudomonas aeruginosa in Dual-Species Biofilms with Acinetobacter baumannii
    Wang, Jing
    Liu, Xi
    Yu, Kaiwei
    Liu, Moxiao
    Qu, Jiuxin
    Liu, Yingxia
    Cai, Zhao
    Wang, Ke
    Zhuo, Chao
    Yang, Liang
    Zhang, Yingdan
    ACS INFECTIOUS DISEASES, 2022, 8 (01): : 129 - 136
  • [36] RESISTANCE TRANSFER FROM ALCALIGENES TO PSEUDOMONAS-AERUGINOSA IN BURNED AND UNBURNED GERMFREE MICE
    MISKELL, PW
    MALEY, MP
    HUMMEL, RP
    SURGICAL FORUM, 1976, 27 : 69 - 70
  • [37] Optimal use of antimicrobials in hospitalized patients. Recommendations for limiting the emergence of bacterial resistance.
    Carlet, J
    Cordonnier, C
    Decazes, JM
    Korinek, AM
    Petitpretz, P
    Rotman, N
    Acar, J
    Benhamou, D
    Beytout, J
    Buisson, Y
    Choutet, P
    Durocher, A
    Jarlier, V
    MlikaCabanne, N
    Monnet, D
    Regnier, B
    Richet, H
    Schlemmer, B
    Sinegre, M
    Soussy, CJ
    Tremolieres, F
    VernetGarnier, V
    Wolff, M
    Abadie, E
    Arduin, M
    BeckGiraudon, B
    Bedock, B
    Berardi, L
    Bernard, C
    Blech, MF
    Bornet, JL
    Boulard, G
    BrunBuisson, C
    Carbon, C
    Chaperon, J
    Charbonneau, P
    Courvalin, P
    David, P
    DeMicco, P
    Desbonnets, GP
    Delcourt, S
    Deroubaix, P
    Desfarges, R
    DHavelooze, A
    Dien, G
    Drucker, J
    Dubernet, J
    Dubois, D
    Ducreux, AM
    Duroux, P
    SEMAINE DES HOPITAUX, 1997, 73 (5-6): : 153 - 158
  • [38] Colistin in the treatment of severely burned patients infected by multiresistant strains of Pseudomonas aeruginosa
    Lipovy, B.
    Rihova, H.
    Hanslianova, M.
    Gregorova, N.
    Kaloudova, Y.
    Mager, R.
    Suchanek, I
    Brychta, P.
    EPIDEMIOLOGIE MIKROBIOLOGIE IMUNOLOGIE, 2010, 59 (04): : 183 - 188
  • [39] Development of a Serum Therapy to Protect Severely Burned Patients from Pseudomonas Aeruginosa
    Bouffard, Emily
    Mudaliar, Nithya S.
    Calmer-Hamood, Jane A.
    Griswold, John A.
    Dissanaike, Sharmila
    Hamood, Abdul N.
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2018, 227 (04) : S261 - S261
  • [40] CURRENT APPROACH TO PREVENTION AND TREATMENT OF PSEUDOMONAS-AERUGINOSA INFECTIONS IN BURNED PATIENTS
    PRUITT, BA
    LINDBERG, RB
    MCMANUS, WF
    MASON, AD
    REVIEWS OF INFECTIOUS DISEASES, 1983, 5 : S889 - S897